ADVANCED IVFPOWERED BY GENETICS
- IVF
- EMBRYOLOGY
- GENETICS & PGT
- MALE INFERTILITY
- FEMALE INFERTILITY
- CARRIER SCREENING
Where reproductive medicine, embryology and advanced genetics come together for one purpose: a healthy pregnancy, a healthy baby.
A REFERENCE CENTER FOR ADVANCED IVF & REPRODUCTIVE GENETICS
A multidisciplinary center for advanced IVF, reproductive genetics and complex infertility, combining personalized medicine with unique reproductive biotechnology solutions by ZEUS, our sister company.
A REFERENCE CENTER FOR ADVANCED IVF & REPRODUCTIVE GENETICS
A multidisciplinary center for advanced IVF, reproductive genetics and complex infertility, combining personalized medicine with unique reproductive biotechnology solutions by ZEUS, our sister company.
IVF · EMBRYOLOGY · GENETICS
One integrated approach bringing together clinical care, laboratory expertise and genetics.
IVF
Your remotely managed, personalized COH treatment minimizes your stay in Ankara.
EMBRYOLOGY
Advanced embryo culture, monitoring, biopsy, cryopreservation and laboratory workflows.
GENETICS
Reproductive genetics and PGT integrated into selected IVF pathways.
ONE PATIENT · ONE EMBRYO · ONE INTEGRATED TEAM
From fertilization to genetic analysis and embryo transfer, every critical step is managed through an integrated clinical, embryological and genetic workflow.
NOTHING ELSE LIKE BIOPSAFE. YOUR EMBRYO STAYS YOURS, FROM BIOPSY TO RESULT.
At Gen-Art, safety comes first. Together with our sister company, we developed the world’s only automated control system that prevents mix-ups at the embryo biopsy stage, making your PGT process extremely safe.
- Built for the biopsy stageDesigned for the step where sample identity matters most.
- Automatic controlChecks are performed by the system, not left to manual verification alone.
- Developed with ZEUSCreated by Gen-Art together with our sister company ZEUS.

Advanced fertility care at the crossroads of Europe, the Middle East and Central Asia.
Accessible
Well connected to international destinations across Europe, the Middle East and Central Asia, with convenient onward travel options.
01Cost-Effective
Advanced IVF and reproductive genetics delivered cost-effectively, in a healthcare environment that combines quality, technology and value.
02Advanced Medical Infrastructure
IVF, embryology, reproductive genetics and molecular diagnostics are coordinated within one integrated treatment pathway.
03Less Time Away From Home
Where medically appropriate, evaluation and treatment preparation can begin remotely, helping international patients minimize their stay in Ankara.
04Every Embryo Matters.That’s Why Every Step Matters.
From fertilization to genetic analysis and embryo transfer, every critical step is managed through an integrated clinical, embryological and genetic workflow.
Optimized embryo culture from fertilization to blastocyst stage.
Continuous assessment of embryo development and morphology.
Precise trophectoderm biopsy for genetic testing when indicated.
Integrated molecular genetic testing through Mikrogen.
Advanced vitrification with monitored storage and identity control.
Embryo selection informed by clinical, embryological and genetic information.
Single embryo transfer, ultrasound-guided and tailored to the individualized treatment plan.
GENETICS IS NOT AN ADD-ON.IT IS PART OF OUR IVF JOURNEY.
Integrating 25+ years of Genetics Division (Mikrogen) diagnostic experience ensures genetic precision is woven into every stage of treatment, avoiding delays and specimen transit risks.
UNIFIED PATIENT & EMBRYO DIAGNOSTIC PATHWAY
End-to-end clinical and laboratory precision without third-party courier risks
Couple Consultation
Clinical History
Genetic Evaluation
Carrier Profiling
Personalized IVF Plan
ICSI & Culture
Embryo Culture & Biopsy
Blastocyst culture and trophectoderm
PGT Analysis
In-house genetic analysis
Integrated Morphokinetic Embryo Evaluation
Embryology and genetic findings
Embryo Transfer
Transfer done
Preimplantation Genetic Testing for Monogenic Diseases
Eliminates transmission of single-gene conditions such as Thalassemia, Cystic Fibrosis, SMA, and Duchenne Muscular Dystrophy before pregnancy begins.
Chromosomal Assessment of Embryos (Aneuploidy)
Analyzes all 23 chromosome pairs using deep NGS data to ensure only euploid embryos with normal chromosome complement are selected.
Structural Chromosome Rearrangements
Selects balanced or normal embryos over those with unbalanced chromosomal segments, helping prevent miscarriage and supporting the birth of a healthy baby.
Comprehensive Couple Carrier Screening
Proactive carrier screening for shared genetic disorders is the first step toward a healthy pregnancy and child.
A LEGACY OF REPRODUCTIVE SCIENCE
From pioneering genetic diagnosis to advances in reproductive biotechnology.
GEN-ART Founded in Ankara
Reproductive medicine, embryology and biotechnology brought together under one clinical vision.
After losing five children to SMA, the Arslan family welcomed Elif through Türkiye’s first PGT for SMA.
First Healthy Baby via PGT for SMA
Piezoelectric Oocyte Activation Research
Clinical research by Baltacı and colleagues demonstrated significantly higher fertilization in selected patients with previous total fertilization failure when ICSI was combined with piezoelectric stimulation.
GEN-ART investigators contributed to clinical research exploring autologous mitochondrial injectioninto oocytes of women with poor oocyte quality.
Mitochondrial Reproductive Research
Scientific Heritage Continues
A multidisciplinary center advancing IVF, reproductive genetics and personalized fertility care in Ankara, Türkiye.
GEN-ART Founded in Ankara
Reproductive medicine, embryology and biotechnology brought together under one clinical vision.
First Healthy Baby via PGT for SMA
After losing five children to SMA, the Arslan family welcomed Elif through Türkiye’s first PGT for SMA.
Piezoelectric Oocyte Activation Research
Clinical research by Baltacı and colleagues demonstrated significantly higher fertilization in selected patients with previous total fertilization failure when ICSI was combined with piezoelectric stimulation.
Mitochondrial Reproductive Research
GEN-ART investigators contributed to clinical research exploring autologous mitochondrial injection into oocytes of women with poor oocyte quality.
Scientific Heritage Continues
A multidisciplinary center advancing IVF, reproductive genetics and personalized fertility care in Ankara, Türkiye.
WE DON’T JUST USE TECHNOLOGYWE DEVELOP IT
From electronic witnessing to embryo biopsy and cryostorage monitoring, our technologies are designed to support identity verification, traceability and laboratory safety throughout the IVF journey.

Digital Witnessing
End-to-end digital witnessing designed to support patient, gamete, embryo and sample identification across critical IVF laboratory stages.

Oocyte Activation
An electrical oocyte activation technology designed for critical selected cases in which fertilization may be affected by insufficient oocyte activation.

Secure Biopsy Workflow
Embryo-level biopsy traceability. Conventional witnessing systems generally verify patient-to-dish identity; BioPSafe extends traceability to the individual embryo and its corresponding biopsy material.

Smart Cryopreservation
Digital cryopreservation and in-tank traceability. An integrated cryopreservation ecosystem designed to combine storage efficiency of up to 4×, digital traceability and controlled handling of embryos and oocytes.
RESULTS WITH CONTEXT
IVF outcomes depend on more than age alone. Treatment history, ovarian reserve, embryo genetics, infertility diagnosis and treatment strategy all matter.
Explore outcomes by patient and treatment profile
Discover Your Own Chances
For this selected group
Cumulative live birth per transfer
Confirmed ultrasound gestational sac
Risk significantly reduced with euploid transfer
These rates are statistical predictions based on Gen-Art data from patients with similar profiles; they are not a guarantee or a binding outcome. Every patient’s journey is unique, so we recommend speaking with our specialists for a personalized assessment.
© 2026 Gen-Art. All rights reserved. These data are the property of Gen-Art and may not be copied, reproduced or used elsewhere without permission.
MULTIPLE DISCIPLINES.ONE TEAM.
Your treatment is planned through an integrated approach bringing together reproductive medicine, embryology, genetics and andrology.
Our Doctors
Clinical evaluation & treatment planning




Prof. Volkan Baltacı, MD, PhD, Surg. Aysun Baltacı, MD, Surg. Sertaç Şen, MD, Mehmet Giray Özçam, MD
Medical Genetics
Genetic evaluation & interpretation




Prof. Volkan Baltacı, MD, PhD, Prof. Evrim Ünsal, PhD, Assoc. Prof. Leyla Özer, MD, PhD, Nazlı Akın, PhD
Embryology
Embryo culture, assessment & laboratory care



Bağdagül Gökçe, Seda Polat, Nagehan Kozak
Andrology
Male-factor evaluation & treatment


Ümmü Gülsüm Ercan, Şükrü Uysal
Multiple expert perspectives. One treatment plan.
YOUR TREATMENT JOURNEY, PLANNED BEFORE YOU TRAVEL.
A short five-step pathway should reassure international patients that their case can be reviewed and the treatment plan organized before arrival.

International Health Tourism Authorization Certificate
Online Consultation
Video consultation with our senior fertility physician and medical geneticist to review prior medical history.
Medical Record Review
Comprehensive multi-board analysis of hormone panels, semen tests, and prior genetic documents.
Personalized Treatment Plan
Tailored stimulation protocol initiated in your home country with remote ultrasound coordination.
Travel to Ankara
Seamless arrival with VIP transfers, luxury partner accommodation, egg retrieval, and sperm collection.
Treatment & Follow-up
Rapid in-house PGT sequencing, optimal embryo transfer, and continuous remote monitoring after returning home.
Talk to an International Patient Coordinator
Our dedicated coordinators speak English, Turkish, Russian, and Arabic. We provide visa medical invitation letters, flight coordination, and clinic scheduling.
